169 related articles for article (PubMed ID: 29028665)
1. Gynecologic cancer in HIV-infected women: treatment and outcomes in a multi-institutional cohort.
Levinson KL; Riedel DJ; Ojalvo LS; Chan W; Angarita AM; Fader AN; Rositch AF
AIDS; 2018 Jan; 32(2):171-177. PubMed ID: 29028665
[TBL] [Abstract][Full Text] [Related]
2. Gynecologic cancer in HIV-positive women: a systematic review and meta-analysis.
Smith AJB; Varma S; Rositch AF; Levinson K
Am J Obstet Gynecol; 2019 Sep; 221(3):194-207.e5. PubMed ID: 30771344
[TBL] [Abstract][Full Text] [Related]
3. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.
Ore RM; Chen Q; DeSimone CP; Miller RW; Baldwin LA; van Nagell JR; Huang B; Tucker TC; Johnson MS; Fredericks TI; Ueland FR
South Med J; 2018 Jun; 111(6):333-341. PubMed ID: 29863220
[TBL] [Abstract][Full Text] [Related]
5. Survival Disparities by Hospital Volume Among American Women With Gynecologic Cancers.
Seagle BL; Strohl AE; Dandapani M; Nieves-Neira W; Shahabi S
JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657373
[TBL] [Abstract][Full Text] [Related]
6. Trends in gynecologic cancer care in North America.
Reade C; Elit L
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):107-29. PubMed ID: 22640706
[TBL] [Abstract][Full Text] [Related]
7. Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data.
John A; Yang B; Shah R
Adv Ther; 2021 Mar; 38(3):1552-1566. PubMed ID: 33537872
[TBL] [Abstract][Full Text] [Related]
8. Does adherence to National Comprehensive Cancer Network guidelines improve pain-related outcomes? An evaluation of inpatient cancer pain management at an academic medical center.
Mearis M; Shega JW; Knoebel RW
J Pain Symptom Manage; 2014 Sep; 48(3):451-8. PubMed ID: 24439844
[TBL] [Abstract][Full Text] [Related]
9. Adherence to National Comprehensive Cancer Network Guidelines is Associated with Improved Survival for Patients with Stage 2A and Stages 2B and 3 Extremity and Superficial Trunk Soft Tissue Sarcoma.
Voss RK; Chiang YJ; Torres KE; Guadagnolo BA; Mann GN; Feig BW; Cormier JN; Roland CL
Ann Surg Oncol; 2017 Oct; 24(11):3271-3278. PubMed ID: 28741122
[TBL] [Abstract][Full Text] [Related]
10. Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer.
Kaslow SR; Ma Z; Hani L; Prendergast K; Vitiello G; Lee AY; Berman RS; Goldberg JD; Correa-Gallego C
J Surg Oncol; 2022 Sep; 126(3):479-489. PubMed ID: 35471731
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Anemia and Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia in Patients With Gynecologic Cancer.
Hufnagel DH; Mehta ST; Ezekwe C; Brown AJ; Beeghly-Fadiel A; Prescott LS
J Natl Compr Canc Netw; 2021 May; 19(5):513-520. PubMed ID: 33524941
[TBL] [Abstract][Full Text] [Related]
12. Association between adherence to posttreatment National Comprehensive Cancer Network (NCCN) surveillance guidelines and detection of recurrent uterine cancer.
Mayer CM; O'Connor RM; Do AT; Cerda VR; Wang SM; Scott ME; Li AJ; Rimel BJ; Manuel MR; Taylor KN; Kim KH
Gynecol Oncol; 2024 Feb; 181():8-11. PubMed ID: 38096674
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic cancer outcomes in the elderly poor: A population-based study.
Doll KM; Meng K; Basch EM; Gehrig PA; Brewster WR; Meyer AM
Cancer; 2015 Oct; 121(20):3591-9. PubMed ID: 26230631
[TBL] [Abstract][Full Text] [Related]
14. Same thyroid cancer, different national practice guidelines: When discordant American Thyroid Association and National Comprehensive Cancer Network surgery recommendations are associated with compromised patient outcome.
Adam MA; Goffredo P; Youngwirth L; Scheri RP; Roman SA; Sosa JA
Surgery; 2016 Jan; 159(1):41-50. PubMed ID: 26435426
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.
Villanueva C; Chang J; Bartell SM; Ziogas A; Bristow R; Vieira VM
J Natl Compr Canc Netw; 2019 Nov; 17(11):1318-1329. PubMed ID: 31693984
[TBL] [Abstract][Full Text] [Related]
16. Institutional validation of breast cancer treatment guidelines.
Minter RM; Spengler KK; Topping DP; Flug R; Copeland EM; Lind DS
J Surg Res; 2001 Sep; 100(1):106-9. PubMed ID: 11516212
[TBL] [Abstract][Full Text] [Related]
17. Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention.
Dottino JA; Cliby WA; Myers ER; Bristow RE; Havrilesky LJ
Gynecol Oncol; 2015 Sep; 138(3):694-9. PubMed ID: 26072441
[TBL] [Abstract][Full Text] [Related]
18. Impact of guideline changes on use or omission of radiation in the elderly with early breast cancer: practice patterns at National Comprehensive Cancer Network institutions.
McCormick B; Ottesen RA; Hughes ME; Javid SH; Khan SA; Mortimer J; Niland JC; Weeks JC; Edge SB
J Am Coll Surg; 2014 Oct; 219(4):796-802. PubMed ID: 25127504
[TBL] [Abstract][Full Text] [Related]
19. Detection of gynecologic cancers in indigent women in an urban inner-city hospital.
Doll KM; Puliaev R; Chor J; Roston A; Patel UA; Patel A
Int J Gynecol Cancer; 2012 Sep; 22(7):1113-7. PubMed ID: 22810968
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of women with gynecologic cancer who enter clinical trials.
Luck MB; McIntire M; Blades N; Robinson W
J Reprod Med; 2005 Jul; 50(7):481-5. PubMed ID: 16130843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
